Dementia deprescribing guideline released for public consultation

The University of Sydney (the developer) has released the Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine in people with dementia for public consultation until 6 July 2017.

The developer will be seeking NHMRC approval of the guideline under section 14A of the National Health and Medical Research Council Act 1992.

To access the guideline and provide comment please go to: